News
“Better Science, Better Health” covers all the major topics around research and innovation in adaptive clinical pathways and patient data usage.
Latest News
The Alliance for Regenerative Medicine (ARM) supports the efforts of the Better Science Better Health IP Consortium
ARM is the leading international advocacy organization representing the gene and cell therapy sector and consists of more than 290 members, including life sciences companies, patient advocacy groups, academic research institutions, and investors.
Digital Citizen, Digital Patient: Estonia’s upcoming – first-ever – EU Presidency will put eHealth high on the agenda
An interview with Ain Aaviksoo, Deputy General Secretary on eServices and Innovation, Ministry of Social Affairs, Estonia.
A key aim of the Presidency is to promote Digital Europe. In eHealth the goal will be to highlight how digital technologies can contribute to the sustainability and resilience of healthcare systems.
Reinventing the European Advanced Therapies Sector: An Interview with Eduardo Bravo
Vital Transformation recently interviewed TiGenix CEO Eduardo Bravo and President of the European Biopharmaceutical Enterprises (EBE) on the implications of this lack of liquidity in Europe.
Digital Citizen, Digital Patient: How EU-funded research can drive the digitisation of health systems in Europe
An interview with Peeter Ross, professor at Tallinn University of Technology
As a participant in eight different EU projects, Peeter Ross, professor at Tallinn University of Technology, can fairly be described as a veteran of European ehealth research.
Digital citizen, digital patient: EMIF is bringing the power of numbers to dementia research
An interview with Simon Lovestone, Professor of Translational Neuroscience at Oxford University, UKMaking data repositories visible and easy to access is transforming translational research in Alzheimer’s disease. “You can answer questions you couldn’t before,” says Simon Lovestone, academic lead of the programme
Digital citizen, digital patient: EMIF makes it as good to give as to receive
An Interview with Nigel Hughes, Scientific Director, Quantitative Sciences at Janssen Research and Development By removing barriers to data exchange, EMIF has provided potent demonstrations of the power of pooling resources in Alzheimer’s disease and metabolic disorders. These exemplars are incentivising data sharing, says Nigel Hughes
Digital citizen, digital patient: How Wearables Can Fill the Data Gaps in Orphan Drug Development
An interview with Elin Haf Davies, CEO and founder of aparito As if the small number of patients is not enough of a hurdle, snapshot and episodic collection methods can make it impossible to amass the data needed to convince regulators and reimbursement agencies that therapies for rare diseases are effective. Wearables can help, says Elin Haf Davies, founder and CEO of aparito.
Podcast: How To Support Advanced Therapies and Breakthrough Medicines in Europe
On the occasion of the first DIA BioVenture day on 28 March 2017 in Glasgow, Menno Aarnout, Wolfgang Stoiber and EBE's Barbara Freischem discussed options for solutions to support the development and funding of Advanced Therapies and Breakthrough Medicines in Europe.
